Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guimarães
Clinical trial register · Portugal

Clinical Trials in Guimarães, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1104 matching records held by the registry are in this view. Synced 30 Oct 2026, 03:17 UTC
1104
Studies in scope
all four open statuses
533
Recruiting now
open to new participants
285
Lead sponsors
across recruiting studies
Top sites
Lisbon 689 Porto 537 Coimbra 256 Braga 182 Vila Nova de Gaia 105
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie10 Janssen Research & Development, LLC7 AstraZeneca4 Sanofi4 Daiichi Sankyo3
Site location
Lisbon689 Porto537 Coimbra256 Braga182 Vila Nova de Gaia105
All 97 locations
Target enrolment
to

Trials with a site in Guimarães

88 of 1104 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Recruiting
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
NCT07690436Transthyretin Amyloid Cardiomyopathy
AstraZeneca
Observational
500
Guimarães, Lisbon
2026-07-08
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Guimarães
2026-06-05
Recruiting
AbbVie
Phase 3
990
Guimarães, Loures, Almada, Lisbon, Porto
2026-05-22
Recruiting
Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality
NCT07789535Hypertension, Poor Sleep Quality, Insomnia, Arterial Stiffness
Unidade Local de Saúde do Alto Ave, EPE
Not applicable
234
Guimarães
2026-05-18
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Coimbra, Guimarães, Setúbal
2026-05-11
Recruiting
Grifols Therapeutics LLC
Phase 3
40
Guimarães, Loures
2026-05-05
Active, closed
Sanofi
Phase 3
59
Guimarães, Porto
2026-03-12
Recruiting
University of Minho
Not applicable
60
Guimarães
2026-01-22
Recruiting
Unidade Local de Saúde do Alto Ave, EPE
Phase 2
30
Guimarães
2026-01-05
Recruiting
AbbVie
Phase 2/3
490
Guimarães, Loures, Senhora da Hora, Braga, Porto
2025-12-10
Recruiting
Bristol-Myers Squibb
Phase 3
650
Coimbra, Guimarães, Lisbon, Senhora da Hora, Torres Vedras
2025-12-02
Recruiting
Hoffmann-La Roche
Phase 3
900
Braga, Coimbra, Funchal, Guimarães, Lisbon, Matosinhos Municipality, Torres Vedras
2025-11-24
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Guimarães, Lisbon
2025-10-06
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Braga, Guimarães, Lisbon, Loures, Porto
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Braga, Guimarães, Lisbon, Loures, Porto, Viana do Castelo
2025-10-01
Recruiting
Sanofi
Phase 3
942
Almada, Braga, Guimarães, Matosinhos Municipality, Porto
2025-09-16
Recruiting
Hydrumedical
Not applicable
134
Aveiro, Guimarães, Lisbon, Viana do Castelo
2025-09-09
Recruiting
GlaxoSmithKline
Phase 3
420
Almada, Coimbra, Guimarães, Lisbon
2025-08-11
Active, closed
Amgen
Phase 3
12,800
Braga, Carnaxide, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Ponte de Lima, Riachos, Torres Novas
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Almada, Amadora, Aveiro, Braga, Coimbra, Guimarães, Leiria, Lisbon
2025-07-22
Recruiting
Bristol-Myers Squibb
Phase 3
586
Torres Vedras, Matosinhos Municipality, Braga, Coimbra, Guimarães, Porto
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
426
Coimbra, Guimarães, Lisbon, Senhora da Hora, Torres Vedras
2025-07-10
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Almada, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2025-06-25
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Aveiro, Braga, Coimbra, Guimarães, Leiria, Lisbon, Porto
2025-06-09
Recruiting
Study on Safety and Performance of AdvanCore Bone Void Filler
NCT06736457Bone Fractures, Bone Defects, Bone Loss, Bone Graft
Artur Salgado SA
Not applicable
190
Guimarães, Porto, Tomar, Lordelo
2025-05-29
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Almada, Braga, Guimarães, Lisbon, Porto
2025-05-22
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Guimarães, Leiria, Lisbon, Porto
2025-04-15
Recruiting
Daiichi Sankyo
Phase 3
726
Braga, Guimarães, Lisbon, Porto
2025-02-27
Active, closed
Sanofi
Phase 3
231
Guimarães, Matosinhos Municipality, Porto, Santa Maria da Feira
2025-02-12
Active, closed
AbbVie
Phase 3
468
Guimarães, Lisbon, Loures, Senhora da Hora, Almada, Aveiro, Braga, Porto
2025-02-10
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Guimarães, Lisbon, Porto
2025-01-08
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Braga, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2024-12-16
Active, closed
AbbVie
Observational
1,314
Guimarães, Lisbon, Loures, Sintra, Torres Vedras, Coimbra, Porto
2024-11-26
Active, closed
University of Trás-os-Montes and Alto Douro
Not applicable
38
Guimarães
2024-11-07
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Guimarães, Lisbon, Torres Vedras, Matosinhos Municipality
2024-09-26
Recruiting
AbbVie
Phase 2
590
Guimarães, Lisbon, Braga, Coimbra, Viana do Castelo
2024-09-04
By invitation
Viatris Innovation GmbH
Phase 3
680
Amadora, Faro, Guarda, Guimarães, Vila Nova de Gaia
2024-07-30
Active, closed
AbbVie
Phase 3
1,400
Guimarães, Lisbon, Porto
2024-06-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Guimarães, Portimão, Leiria, Lisbon, Viana do Castelo, Viseu
2024-06-05
Recruiting
Daiichi Sankyo
Phase 3
540
Coimbra, Guimarães, Lisbon, Porto
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Guimarães, Coimbra, Almada, Braga, Guarda, Porto, Vila Nova de Gaia
2024-05-20
Active, closed
Novo Nordisk A/S
Phase 2
88
Guimarães, Vila Real
2024-02-20
Active, closed
Sanofi
Phase 3
1,655
Braga, Coimbra, Guimarães, Lisbon, Matosinhos Municipality
2023-12-13
Recruiting
Novartis Pharmaceuticals
Observational
174
Amadora, Guimarães, Leiria, Lisbon, Matosinhos Municipality, Ponte de Lima, Porto, Setúbal
2023-11-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Guimarães, Lisbon, Torres Vedras, Matosinhos Municipality
2023-07-11
Active, closed
Viatris Innovation GmbH
Phase 3
451
Amadora, Faro, Guarda, Guimarães, Lisbon, Vila Nova de Gaia
2023-06-26
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira, Vila Real
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Braga, Guimarães, Lisbon, Matosinhos Municipality
2023-05-08
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira
2023-04-25
Active, closed
The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
NCT06416644Lower Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia, Chronic Limb Ischemia
Hospital do Divino Espírito Santo de Ponta Delgada
Not applicable
100
Faro, Ponta Delgada, Almada, Penafiel, Vila Nova de Gaia, Angra do Heroísmo, Coimbra, Guimarães
2023-04-01
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Coimbra, Guimarães, Porto, Torres Vedras
2023-03-31
Recruiting
AstraZeneca
Phase 3
4,300
Amadora, Braga, Guimarães, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Braga, Coimbra, Covilha, Guimarães, Lisbon, Porto, Pragal, Santa Maria da Feira
2023-02-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira
2023-02-14
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Braga, Guimarães, Lisbon, Viana do Castelo
2023-01-16
Active, closed
Ipsen
Phase 2
68
Guimarães, Lisbon
2022-12-29
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Guimarães, Lisbon, Porto
2022-11-30
Active, closed
GlaxoSmithKline
Phase 2
351
Gaia, Guimarães, Lisbon, Porto
2022-10-14
Active, closed
Exelixis
Phase 3
901
Almada, Coimbra, Guimarães, Lisbon
2022-09-07
Recruiting
Multigen Plus CCK and AMF TT Cones Follow Up Study
NCT05314491Total Knee Arthroplasty, Revision Total Knee Arthroplasty
Limacorporate S.p.a
Observational
68
Guimarães
2022-06-21
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Almada, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto
2021-12-02
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Alcabideche, Almada, Carnaxide, Coimbra, Guimarães, Leiria, Lisbon, Matosinhos Municipality
2021-11-23
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Lisbon, Vila Nova de Gaia, Guimarães, Loures, Porto, Vila Real
2021-08-27
Active, closed
Inventiva Pharma
Phase 3
1,000
Braga, Guimarães, Lisbon, Porto, Senhora da Hora, Vila Real
2021-08-19
Active, closed
AstraZeneca
Phase 3
315
Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2021-06-30
Recruiting
Ipsen
Phase 1/2
240
Guimarães, Loures, Matosinhos Municipality, Viana do Castelo
2021-04-29
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Senhora Da Hora, Matosinhos, Almada, Aveiro, Braga, Guarda, Guimarães, Lisbon, Porto
2021-04-01
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Almada, Braga, Coimbra, Guimarães, Lisbon, Loures, Porto, Santa Maria da Feira
2021-02-23
Active, closed
AstraZeneca
Phase 3
1,371
Braga, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2021-01-28
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Almada, Aveiro, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia, Vila Real
2020-12-18
Active, closed
Daiichi Sankyo
Phase 3
1,600
Guimarães, Lisbon, Loures, Matosinhos Municipality, Porto, Vila Nova de Gaia
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Coimbra, Guimarães, Lisbon, Porto, Vila Nova de Gaia
2020-12-02
Active, closed
Exelixis
Phase 3
575
Braga, Guimarães, Lisbon, Loures, Porto, Vila Real
2020-10-19
Active, closed
Medtronic
Observational
2,200
Guimarães, Lisbon, Porto, Santarém
2020-08-01
Active, closed
Medtronic
Observational
2,200
Guimarães, Lisbon, Porto, Santarém
2020-08-01
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Lisbon, Coimbra, Faro, Guimarães, Porto
2019-11-26
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084Tachycardia, Atrial Fibrillation, Syncope, Bradycardia
Biotronik SE & Co. KG
Observational
1,400
Guimarães, Lisbon
2019-10-28
Active, closed
Pfizer
Phase 3
896
Coimbra, Vila Nova de Gaia, Guimarães, Porto
2019-09-05
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Senhora Da Hora, Matosinhos, Almada, Aveiro, Coimbra, Guimarães, Lisbon, Porto, Setúbal
2019-05-08
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
Braga, Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira, Setúbal, Vila Real
2018-11-28
Active, closed
AbbVie
Phase 3
1,242
Guimarães, Portimão, Santa Maria DA Feira, Almada, Coimbra, Lisbon, Porto, Viseu
2018-08-28
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Braga, Coimbra, Guimarães, Portimão, Porto, Santa Maria da Feira
2018-04-13
Active, closed
AbbVie
Phase 3
1,336
Guimarães, Portimão, Lisbon, Santa Maria DA Feira, Almada, Faro, Loures, Porto
2018-04-09
Active, closed
AbbVie
Phase 3
747
Guimarães, Lisbon, Almada, Ponte de Lima, Porto
2018-03-21
Active, closed
Medtronic
Observational
1,092
Guimarães, Lisbon, Porto, Santarém
2017-08-21
Active, closed
MedSIR
Phase 2
377
Guimarães, Lisbon, Porto, Vila Real
2017-06-26
Active, closed
AbbVie
Phase 3
950
Guimarães, Santa Maria DA Feira, Almada, Braga, Lisbon, Porto, Viana do Castelo
2017-01-31
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Guimarães, Lisbon
2013-05-30
Rows per page Showing 1–88 of 88
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-portugal/city/guimar-es

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,104 studies in total at the last sync on 30 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 88 of those studies with a site in Guimarães.

How many clinical trials are recruiting in Guimarães?

40 of the 88 studies on this page are recruiting new participants as of the 30 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 45 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guimarães), 88 studies
PhaseStudiesRecruitingShare
Phase 3582365.9%
Phase 210411.4%
Observational9510.2%
Not applicable646.8%
Phase 2/3434.5%
Phase 1/2111.1%

Most active sponsors

Lead sponsors with the most studies (Guimarães)
Lead sponsorStudiesRecruiting
AbbVie103
Janssen Research & Development, LLC73
AstraZeneca42
Sanofi41
Bristol-Myers Squibb33
Daiichi Sankyo32
Medtronic30
Novartis Pharmaceuticals31
Novo Nordisk A/S30
Xenon Pharmaceuticals Inc.32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.